Grant: Idea to Innovation
McMaster University
$125,000.00
Microplate based LSPR biosensors
EF 2022-23
Résumé
Interactions between biomolecules underlie all biochemical processes and so are central to therapeutics and biotechnology. Understanding the strengths of these interactions is thus fundamental to the development of new technologies. Label-free techniques such as local surface plasmon resonance (LSPR) are the gold standard for measuring these important interactions, but access to LSPR instrumentation is limited due to expensive, specialized optical equipment. Current commercial sensors are also limited by non-specific interactions, and can't be easily used in complex environments such as blood, which further hinders utility. To overcome these two main limitations of this important technique, we have developed a new type of sensor for use in a plate reader, which is a common piece of laboratory equipment, and which uses a scalable technique to produce a coating that reduces the non-specific interactions. So far, this new and accessible LSPR platform has garnered attention from both industry leading plate reader manufacturers and therapeutic development companies. This proposal includes a work plan that will translate our proof-of-concept sensors into an automated fluid handling platform which is compatible with common plate readers and expand the chemistry of the coatings to allow the sensors to be used with a broader range of analytical targets relevant to therapeutic development. By the end of this I2I project period, we aim to develop a working platform that can be used by therapeutic developers and licensed with a manufacturing partner.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
576563-2022
Name nom
Wylie, Ryan G
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
Microplate based LSPR biosensors
Application summary
Interactions between biomolecules underlie all biochemical processes and so are central to therapeutics and biotechnology. Understanding the strengths of these interactions is thus fundamental to the development of new technologies. Label-free techniques such as local surface plasmon resonance (LSPR) are the gold standard for measuring these important interactions, but access to LSPR instrumentation is limited due to expensive, specialized optical equipment. Current commercial sensors are also limited by non-specific interactions, and can't be easily used in complex environments such as blood, which further hinders utility. To overcome these two main limitations of this important technique, we have developed a new type of sensor for use in a plate reader, which is a common piece of laboratory equipment, and which uses a scalable technique to produce a coating that reduces the non-specific interactions. So far, this new and accessible LSPR platform has garnered attention from both industry leading plate reader manufacturers and therapeutic development companies. This proposal includes a work plan that will translate our proof-of-concept sensors into an automated fluid handling platform which is compatible with common plate readers and expand the chemistry of the coatings to allow the sensors to be used with a broader range of analytical targets relevant to therapeutic development. By the end of this I2I project period, we aim to develop a working platform that can be used by therapeutic developers and licensed with a manufacturing partner.